These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care. Pearlman BL. Lancet Infect Dis; 2012 Sep; 12(9):717-28. PubMed ID: 22647717 [Abstract] [Full Text] [Related]
17. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy. Sultanik P, Mallet V, Lagaye S, Casrouge A, Dorival C, Barthe Y, Fontaine H, Hézode C, Mottez E, Bronowicki JP, Carrat F, Theodorou I, Abel L, Gayat E, Fontanet A, Pol S, Albert ML, ANRS CO20-CUPIC. Liver Int; 2015 Jul; 35(7):1833-44. PubMed ID: 25556540 [Abstract] [Full Text] [Related]
20. [Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection]. Macías J, Rivero A. Enferm Infecc Microbiol Clin; 2013 Jul; 31 Suppl 3():33-6. PubMed ID: 24063901 [Abstract] [Full Text] [Related] Page: [Next] [New Search]